1065 related articles for article (PubMed ID: 29998336)
1. Effect of a Home-Based Wearable Continuous ECG Monitoring Patch on Detection of Undiagnosed Atrial Fibrillation: The mSToPS Randomized Clinical Trial.
Steinhubl SR; Waalen J; Edwards AM; Ariniello LM; Mehta RR; Ebner GS; Carter C; Baca-Motes K; Felicione E; Sarich T; Topol EJ
JAMA; 2018 Jul; 320(2):146-155. PubMed ID: 29998336
[TBL] [Abstract][Full Text] [Related]
2. Three year clinical outcomes in a nationwide, observational, siteless clinical trial of atrial fibrillation screening-mHealth Screening to Prevent Strokes (mSToPS).
Steinhubl SR; Waalen J; Sanyal A; Edwards AM; Ariniello LM; Ebner GS; Baca-Motes K; Zambon RA; Sarich T; Topol EJ
PLoS One; 2021; 16(10):e0258276. PubMed ID: 34610049
[TBL] [Abstract][Full Text] [Related]
3. Effect of Continuous Electrocardiogram Monitoring on Detection of Undiagnosed Atrial Fibrillation After Hospitalization for Cardiac Surgery: A Randomized Clinical Trial.
Ha ACT; Verma S; Mazer CD; Quan A; Yanagawa B; Latter DA; Yau TM; Jacques F; Brown CD; Singal RK; Yamashita MH; Saha T; Teoh KH; Lam BK; Deyell MW; Wilson M; Hibino M; Cheung CC; Kosmopoulos A; Garg V; Brodutch S; Teoh H; Zuo F; Thorpe KE; Jüni P; Bhatt DL; Verma A;
JAMA Netw Open; 2021 Aug; 4(8):e2121867. PubMed ID: 34448866
[TBL] [Abstract][Full Text] [Related]
4. Cost-Effectiveness of AF Screening With 2-Week Patch Monitors: The mSToPS Study.
Reynolds MR; Stein AB; Sun X; Hytopoulos E; Steinhubl SR; Cohen DJ
Circ Cardiovasc Qual Outcomes; 2023 Nov; 16(11):e009751. PubMed ID: 37905421
[TBL] [Abstract][Full Text] [Related]
5. Screening for Atrial Fibrillation in the Older Population: A Randomized Clinical Trial.
Gladstone DJ; Wachter R; Schmalstieg-Bahr K; Quinn FR; Hummers E; Ivers N; Marsden T; Thornton A; Djuric A; Suerbaum J; von Grünhagen D; McIntyre WF; Benz AP; Wong JA; Merali F; Henein S; Nichol C; Connolly SJ; Healey JS;
JAMA Cardiol; 2021 May; 6(5):558-567. PubMed ID: 33625468
[TBL] [Abstract][Full Text] [Related]
6. Rationale and design of a home-based trial using wearable sensors to detect asymptomatic atrial fibrillation in a targeted population: The mHealth Screening To Prevent Strokes (mSToPS) trial.
Steinhubl SR; Mehta RR; Ebner GS; Ballesteros MM; Waalen J; Steinberg G; Van Crocker P; Felicione E; Carter CT; Edmonds S; Honcz JP; Miralles GD; Talantov D; Sarich TC; Topol EJ
Am Heart J; 2016 May; 175():77-85. PubMed ID: 27179726
[TBL] [Abstract][Full Text] [Related]
7. Chronic kidney disease and undiagnosed atrial fibrillation in individuals with diabetes.
Heo NJ; Rhee SY; Waalen J; Steinhubl S
Cardiovasc Diabetol; 2020 Sep; 19(1):157. PubMed ID: 32998739
[TBL] [Abstract][Full Text] [Related]
8. Effect of Implantable vs Prolonged External Electrocardiographic Monitoring on Atrial Fibrillation Detection in Patients With Ischemic Stroke: The PER DIEM Randomized Clinical Trial.
Buck BH; Hill MD; Quinn FR; Butcher KS; Menon BK; Gulamhusein S; Siddiqui M; Coutts SB; Jeerakathil T; Smith EE; Khan K; Barber PA; Jickling G; Reyes L; Save S; Fairall P; Piquette L; Kamal N; Chew DS; Demchuk AM; Shuaib A; Exner DV
JAMA; 2021 Jun; 325(21):2160-2168. PubMed ID: 34061146
[TBL] [Abstract][Full Text] [Related]
9. Healthcare resource utilization following ECG sensor patch screening for atrial fibrillation.
Waalen J; Edwards AM; Sanyal A; Zambon RA; Ariniello L; Ebner GS; Baca-Motes K; Carter C; Felicione E; Sarich T; Topol EJ; Steinhubl SR
Heart Rhythm O2; 2020 Dec; 1(5):351-358. PubMed ID: 34113893
[TBL] [Abstract][Full Text] [Related]
10. Detection of Atrial Fibrillation in a Large Population Using Wearable Devices: The Fitbit Heart Study.
Lubitz SA; Faranesh AZ; Selvaggi C; Atlas SJ; McManus DD; Singer DE; Pagoto S; McConnell MV; Pantelopoulos A; Foulkes AS
Circulation; 2022 Nov; 146(19):1415-1424. PubMed ID: 36148649
[TBL] [Abstract][Full Text] [Related]
11. A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study.
Hobbs FD; Fitzmaurice DA; Mant J; Murray E; Jowett S; Bryan S; Raftery J; Davies M; Lip G
Health Technol Assess; 2005 Oct; 9(40):iii-iv, ix-x, 1-74. PubMed ID: 16202350
[TBL] [Abstract][Full Text] [Related]
12. Effect of Long-term Continuous Cardiac Monitoring vs Usual Care on Detection of Atrial Fibrillation in Patients With Stroke Attributed to Large- or Small-Vessel Disease: The STROKE-AF Randomized Clinical Trial.
Bernstein RA; Kamel H; Granger CB; Piccini JP; Sethi PP; Katz JM; Vives CA; Ziegler PD; Franco NC; Schwamm LH;
JAMA; 2021 Jun; 325(21):2169-2177. PubMed ID: 34061145
[TBL] [Abstract][Full Text] [Related]
13. Association of Surgical Left Atrial Appendage Occlusion With Subsequent Stroke and Mortality Among Patients Undergoing Cardiac Surgery.
Yao X; Gersh BJ; Holmes DR; Melduni RM; Johnsrud DO; Sangaralingham LR; Shah ND; Noseworthy PA
JAMA; 2018 May; 319(20):2116-2126. PubMed ID: 29800182
[TBL] [Abstract][Full Text] [Related]
14. Effects of rivaroxaban versus warfarin on hospitalization days and other health care resource utilization in patients with nonvalvular atrial fibrillation: an observational study from a cohort of matched users.
Laliberté F; Cloutier M; Crivera C; Nelson WW; Olson WH; Schein J; Vanderpoel J; Germain G; Lefebvre P
Clin Ther; 2015 Mar; 37(3):554-62. PubMed ID: 25749196
[TBL] [Abstract][Full Text] [Related]
15. Incremental yield of ECG screening repeated annually over 4 years in an adult Japanese population without prior atrial fibrillation: a retrospective cohort study.
Nagata Y; Yamagami T; Nutbeam D; Freedman B; Lowres N
BMJ Open; 2020 Jul; 10(7):e035650. PubMed ID: 32690510
[TBL] [Abstract][Full Text] [Related]
16. Role of Outpatient Cardiac Rhythm Monitoring in Cryptogenic Stroke: A Systematic Review and Meta-Analysis.
Afzal MR; Gunda S; Waheed S; Sehar N; Maybrook RJ; Dawn B; Lakkireddy D
Pacing Clin Electrophysiol; 2015 Oct; 38(10):1236-45. PubMed ID: 26172621
[TBL] [Abstract][Full Text] [Related]
17. Severity and Etiology of Incident Stroke in Patients Screened for Atrial Fibrillation vs Usual Care and the Impact of Prior Stroke: A Post Hoc Analysis of the LOOP Randomized Clinical Trial.
Diederichsen SZ; Frederiksen KS; Xing LY; Haugan KJ; Højberg S; Brandes A; Graff C; Olesen MS; Krieger D; Køber L; Svendsen JH
JAMA Neurol; 2022 Oct; 79(10):997-1004. PubMed ID: 36036546
[TBL] [Abstract][Full Text] [Related]
18. Relationship between diabetes mellitus and atrial fibrillation prevalence in the Polish population: a report from the Non-invasive Monitoring for Early Detection of Atrial Fibrillation (NOMED-AF) prospective cross-sectional observational study.
Gumprecht J; Lip GYH; Sokal A; Średniawa B; Mitręga K; Stokwiszewski J; Wierucki Ł; Rajca A; Rutkowski M; Zdrojewski T; Grodzicki T; Kaźmierczak J; Opolski G; Kalarus Z
Cardiovasc Diabetol; 2021 Jun; 20(1):128. PubMed ID: 34167520
[TBL] [Abstract][Full Text] [Related]
19. Predictors of Atrial Fibrillation in Patients With Stroke Attributed to Large- or Small-Vessel Disease: A Prespecified Secondary Analysis of the STROKE AF Randomized Clinical Trial.
Schwamm LH; Kamel H; Granger CB; Piccini JP; Katz JM; Sethi PP; Sidorov EV; Kasner SE; Silverman SB; Merriam TT; Franco N; Ziegler PD; Bernstein RA;
JAMA Neurol; 2023 Jan; 80(1):99-103. PubMed ID: 36374508
[TBL] [Abstract][Full Text] [Related]
20. Trends in Atrial Fibrillation Incidence Rates Within an Integrated Health Care Delivery System, 2006 to 2018.
Williams BA; Chamberlain AM; Blankenship JC; Hylek EM; Voyce S
JAMA Netw Open; 2020 Aug; 3(8):e2014874. PubMed ID: 32857147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
